methylene blue has been researched along with Hemorrhagic Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvi, AW; Meilleur, G; Shojania, AM | 1 |
1 other study(ies) available for methylene blue and Hemorrhagic Disorders
| Article | Year |
|---|---|
An autoantibody with potent antithrombin activity whose action could be inhibited by toluidine blue or methylene blue.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Blood Coagulation; Calcium; Hemorrhagic Disorders; Hexadimethrine Bromide; Humans; Hydrogen-Ion Concentration; Immunoglobulin G; Male; Methylene Blue; Protamines; Thrombin; Thrombin Time; Tolonium Chloride | 1987 |